Literature DB >> 21593115

Incretin hormone and insulin responses to oral versus intravenous lipid administration in humans.

Ola Lindgren1, Richard D Carr, Carolyn F Deacon, Jens J Holst, Giovanni Pacini, Andrea Mari, Bo Ahrén.   

Abstract

CONTEXT: The incretin effect is responsible for the higher insulin response to oral glucose than to iv glucose at matching glucose levels. It is not known whether this effect is restricted to glucose only.
OBJECTIVE: The aim of the study was to examine whether insulin and incretin hormone responses are higher after oral vs. iv challenge of a lipid emulsion with matching triglyceride levels in humans. DESIGN, SETTINGS, AND PARTICIPANTS: A lipid emulsion (Intralipid) was administered orally (3 ml/kg) or iv (variable infusion rates to match triglyceride levels after oral ingestion) in healthy lean males (n = 12) at a University Clinical Research Unit. Samples were collected during 300 min. MAIN OUTCOME MEASURES: We measured the suprabasal area under the curve for insulin, glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and the insulin secretory rate based on C-peptide levels by deconvolution.
RESULTS: Triglyceride levels increased similarly after oral and iv lipid; also, glucose and free fatty acid levels were similar in the two tests. Oral lipid elicited a clear insulin and C-peptide response, whereas no insulin or C-peptide responses were observed during iv lipid. Total and intact GIP and GLP-1 levels both increased after oral lipid administration but were not significantly altered after iv lipid.
CONCLUSIONS: At matching triglyceride levels and with no difference in glucose and free fatty acid levels, oral lipid ingestion but not iv lipid infusion elicits a clear insulin response in association with increased GIP and GLP-1 concentrations. This may suggest that the incretin hormones also contribute to the islet response to noncarbohydrate nutrients.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21593115     DOI: 10.1210/jc.2011-0266

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  47 in total

1.  Rapid gut growth but persistent delay in digestive function in the postnatal period of preterm pigs.

Authors:  Carl Frederik Hansen; Thomas Thymann; Anders Daniel Andersen; Jens Juul Holst; Bolette Hartmann; Linda Hilsted; Louise Langhorn; Jacob Jelsing; Per Torp Sangild
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-01-28       Impact factor: 4.052

2.  Preoperative β-cell function in patients with type 2 diabetes is important for the outcome of Roux-en-Y gastric bypass surgery.

Authors:  Michael Taulo Lund; Merethe Hansen; Stinna Skaaby; Sina Dalby; Mikael Støckel; Andrea Karen Floyd; Karsten Bech; Jørn Wulff Helge; Jens Juul Holst; Flemming Dela
Journal:  J Physiol       Date:  2015-06-17       Impact factor: 5.182

Review 3.  Physiology of incretins in health and disease.

Authors:  Carolyn F Deacon; Bo Ahrén
Journal:  Rev Diabet Stud       Date:  2011-11-10

4.  Critical role for GLP-1 in symptomatic post-bariatric hypoglycaemia.

Authors:  Colleen M Craig; Li-Fen Liu; Carolyn F Deacon; Jens J Holst; Tracey L McLaughlin
Journal:  Diabetologia       Date:  2016-12-14       Impact factor: 10.122

5.  GIP(3-30)NH2 is an efficacious GIP receptor antagonist in humans: a randomised, double-blinded, placebo-controlled, crossover study.

Authors:  Lærke S Gasbjerg; Mikkel B Christensen; Bolette Hartmann; Amalie R Lanng; Alexander H Sparre-Ulrich; Maria B N Gabe; Flemming Dela; Tina Vilsbøll; Jens J Holst; Mette M Rosenkilde; Filip K Knop
Journal:  Diabetologia       Date:  2017-09-25       Impact factor: 10.122

6.  Women with prior gestational diabetes mellitus and prediabetes are characterised by a decreased incretin effect.

Authors:  Signe Foghsgaard; Louise Vedtofte; Camilla Andreasen; Emilie S Andersen; Emilie Bahne; Jonatan I Bagger; Jens A Svare; Jens J Holst; Tine D Clausen; Elisabeth R Mathiesen; Peter Damm; Filip K Knop; Tina Vilsbøll
Journal:  Diabetologia       Date:  2017-03-31       Impact factor: 10.122

7.  Differential Effects of Oral and Intravenous Lipid Administration on Key Molecules Related to Energy Homeostasis.

Authors:  Maria T Vamvini; Ole-Petter Hamnvik; Ayse Sahin-Efe; Anna Gavrieli; Fadime Dincer; Olivia M Farr; Christos S Mantzoros
Journal:  J Clin Endocrinol Metab       Date:  2016-03-10       Impact factor: 5.958

8.  Genetic determinants of circulating GIP and GLP-1 concentrations.

Authors:  Peter Almgren; Andreas Lindqvist; Ulrika Krus; Liisa Hakaste; Emilia Ottosson-Laakso; Olof Asplund; Emily Sonestedt; Rashmi B Prasad; Esa Laurila; Marju Orho-Melander; Olle Melander; Tiinamaija Tuomi; Jens Juul Holst; Peter M Nilsson; Nils Wierup; Leif Groop; Emma Ahlqvist
Journal:  JCI Insight       Date:  2017-11-02

9.  GLP-1 released to the mesenteric lymph duct in mice: effects of glucose and fat.

Authors:  Lena Ohlsson; Alison B Kohan; Patrick Tso; Bo Ahrén
Journal:  Regul Pept       Date:  2014-02-28

10.  Exaggerated release and preserved insulinotropic action of glucagon-like peptide-1 underlie insulin hypersecretion in glucose-tolerant individuals after Roux-en-Y gastric bypass.

Authors:  Carsten Dirksen; Kirstine N Bojsen-Møller; Nils B Jørgensen; Siv H Jacobsen; Viggo B Kristiansen; Lars S Naver; Dorte L Hansen; Dorte Worm; Jens J Holst; Sten Madsbad
Journal:  Diabetologia       Date:  2013-09-19       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.